Details for Patent: 8,206,741

✉ Email this page to a colleague

Summary for Patent: 8,206,741

Title:	Pharmaceutical compositions for the coordinated delivery of NSAIDs
Abstract:	The present invention is directed to drug dosage forms that release an agent that raises the pH of a patient's gastrointestinal tract, followed by a non-steroidal anti-inflammatory drug. The dosage form is designed so that the NSAID is not released until the intragastric pH has been raised to a safe level. The invention also encompasses methods of treating patients by administering this coordinated release, gastroprotective, antiarthritic/analgesic combination unit dosage form to achieve pain and symptom relief with a reduced risk of developing gastrointestinal damage such as ulcers, erosions and hemorrhages.
Inventor(s):	Plachetka; John R. (Chapel Hill, NC)
Assignee:	POZEN Inc. (Chapel Hill, NC)
Application Number:	11/129,320
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,206,741
Patent Claim Types: see list of patent claims	Composition; Dosage form; Use;

Drugs Protected by US Patent 8,206,741

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,206,741

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1411900	⤷ Sign Up	C300481	Netherlands	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	91858	Luxembourg	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	1190013-1	Sweden	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	CA 2012 00036	Denmark	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	2011/016	Ireland	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	SPC/GB11/015	United Kingdom	⤷ Sign Up
European Patent Office	1411900	⤷ Sign Up	C01411900/01	Switzerland	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.